Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial management strategies for dyspepsia.

B Delaney1, A C Ford, D Forman

  • 1Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham, West Midlands, UK B15 2TT. b.c.delaney@bham.ac.uk

The Cochrane Database of Systematic Reviews
|October 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026
Same author

The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance.

Alimentary pharmacology & therapeutics·2026

Proton pump inhibitors (PPIs) effectively treat dyspepsia, offering better symptom relief than histamine H2-receptor antagonists (H2RAs) or antacids. Early endoscopy or H. pylori testing for dyspepsia management is not cost-effective.

Area of Science:

  • Gastroenterology
  • Evidence-Based Medicine
  • Health Economics

Background:

  • Dyspepsia, encompassing epigastric pain and heartburn, requires effective management strategies.
  • Current approaches involve initial investigations and empirical treatments.

Purpose of the Study:

  • To evaluate the effectiveness, acceptability, and cost-effectiveness of different initial management strategies for dyspepsia.
  • Strategies include pharmacological therapy, early endoscopy, Helicobacter pylori (H. pylori) testing, and eradication therapy.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials in primary care patients with dyspepsia.
  • Data on symptoms, quality of life, and resource utilization were analyzed.

Main Results:

Related Experiment Videos

  • Proton pump inhibitors (PPIs) demonstrated significantly higher efficacy than H2RAs and antacids for dyspepsia symptom control.
  • Early endoscopy showed a slight reduction in recurrent symptoms compared to H. pylori test and treat but was not cost-effective.
  • H. pylori test and treat strategies may be more effective than acid suppression alone.

Conclusions:

  • PPIs are effective for dyspepsia, though trial populations may include gastro-oesophageal reflux disease (GORD) patients.
  • The comparative efficacy of H2RAs and PPIs remains uncertain.
  • While early investigations like endoscopy or H. pylori testing may offer benefits, they are not cost-effective as primary management strategies for all dyspepsia patients.